Evidence map›Paper›PMID 38625627›Full record

ArticleHormones (Athens, Greece)2024

Synergistic neuroprotective action of prolactin and 17β-estradiol on kainic acid-induced hippocampal injury and long-term memory deficit in ovariectomized rats.

Karen De la Torre, Marco Antonio Cerbón, Gladys Molina-Salinas, José Eduardo Suárez-Santiago, Jean-Pascal Morin, Gabriel Roldán-Roldán, Ofir Picazo

Abstract read
PubMed Publisher
In one paragraph

Article in Hormones (Athens, Greece), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Karen De la TorreEscuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón s/n, Col. Sto. Tomás, 11340. Ciudad de México, Ciudad de México, México.
Marco Antonio CerbónFacultad de Química, Universidad Nacional Autónoma de México, Ciudad de México, México.
Gladys Molina-SalinasFacultad de Química, Universidad Nacional Autónoma de México, Ciudad de México, México.
José Eduardo Suárez-SantiagoEscuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón s/n, Col. Sto. Tomás, 11340. Ciudad de México, Ciudad de México, México.
Jean-Pascal MorinDepartamento de Fisiología, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, México.
Gabriel Roldán-RoldánDepartamento de Fisiología, Facultad de Medicina, Universidad Nacional Autónoma de México, Ciudad de México, México. gabaergico@gmail.com.
Ofir PicazoEscuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón s/n, Col. Sto. Tomás, 11340. Ciudad de México, Ciudad de México, México. rifo99mx@gmail.com.ORCID http://orcid.org/0000-0003-4320-4997
Universidad Nacional Autónoma de México · MXInstituto Politécnico Nacional · MXUniversidad Autónoma de Chiapas · MXUniversidad Autónoma de la Ciudad de México · MX

Funding

UNIVERSIDAD AUTONOMA DE MEXICO IN224019UNIVERSIDAD AUTONOMA DE MEXICO IN227123
6 · The paper itself

Abstract

purposeThe neuroprotective actions of the ovarian hormone 17β-estradiol (E2) against different brain lesions have been constantly confirmed in a variety of models including kainic acid (KA) lesions. Similarly, the pituitary hormone prolactin (PRL), traditionally associated with lactogenesis, has recently been linked to a large diversity of functions, including neurogenesis, neuroprotection, and cognitive processes. While the mechanisms of actions of E2 as regards its neuroprotective and behavioral effects have been extensively explored, the molecular mechanisms of PRL related to these roles remain under investigation. The current study aimed to investigate whether the simultaneous administration of PRL and a low dose of E2 prevents the KA-induced cognitive deficit and if this action is associated with changes in hippocampal neuronal density.

methodsOvariectomized (OVX) rats were treated with saline, PRL, and/or E2 in the presence or absence of KA. Neuroprotection was assessed by Nissl staining and neuron counting. Memory was evaluated with the novel object recognition test (NOR).

resultsOn their own, both PRL and E2 prevented short- and long-term memory deficits in lesioned animals and exerted neuroprotection against KA-induced excitotoxicity in the hippocampus. Interestingly, the combined hormonal treatment was superior to either of the treatments administered alone as regards improving both memory and neuronal survival.

conclusionTaken together, these results point to a synergic effect of E2 and PRL in the hippocampus to produce their behavioral, proliferative, and neuroprotective effects.

Indexed as

EstradiolHippocampusKainic AcidMemory DisordersNeuroprotective AgentsOvariectomyProlactinAnimalsDrug SynergismFemaleNeuronsRatsRats, WistarEstradiolKainic AcidNeuroprotective AgentsProlactinEstradiolHippocampusKainic acidProlactinRecognition memory

Identifiers

PMID38625627
OpenAlexW4394853982

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.